Immunogenic composition and method of developing a vaccine based on portions of the HIV matrix protein

Details for Australian Patent Application No. 2004283288 (hide)

Owner Karp, N.

Inventors Karp, Nelson M.

Agent Ahearn Fox

Pub. Number AU-B-2004283288

PCT Pub. Number WO2005/040365

Priority 60/513,827 23.10.03 US

Filing date 25 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 9 September 2010

International Classifications

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040365 Priority application(s): WO2005/040365

26 March 2009 Assignment before Grant

  NMK Research, LLC The application has been assigned to Karp, Nelson

9 September 2010 Application Accepted

  Published as AU-B-2004283288

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283291-Simplified tissue processing

2004283287-Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site